0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Genomic Biomarkers Market Research Report 2025
Published Date: September 2025
|
Report Code: QYRE-Auto-4Y4219
Home | Market Reports | Business & Industrial| Pharmaceuticals & Biotech
Global Genomic Biomarkers Market Insights and Forecast to 2028
BUY CHAPTERS

Global Genomic Biomarkers Market Research Report 2025

Code: QYRE-Auto-4Y4219
Report
September 2025
Pages:81
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Genomic Biomarkers Market

The global market for Genomic Biomarkers was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
North American market for Genomic Biomarkers is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Asia-Pacific market for Genomic Biomarkers is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The global market for Genomic Biomarkers in Diagnostic and Research Laboratories is estimated to increase from $ million in 2024 to $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The major global companies of Genomic Biomarkers include Thermo Fisher Scientific, Roche, Aepodia, Myriad Genetics, Eurofins Scientific, QIAGEN, Bio-Rad Laboratories, Genomic Health, Liquid Genomics, Epigenomics, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Genomic Biomarkers, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Genomic Biomarkers.
The Genomic Biomarkers market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Genomic Biomarkers market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Genomic Biomarkers companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation

Scope of Genomic Biomarkers Market Report

Report Metric Details
Report Name Genomic Biomarkers Market
Segment by Type
  • Oncology
  • Cardiovascular Diseases
  • Neurological Diseases
  • Others
Segment by Application
  • Diagnostic and Research Laboratories
  • Hospitals
  • Others
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Thermo Fisher Scientific, Roche, Aepodia, Myriad Genetics, Eurofins Scientific, QIAGEN, Bio-Rad Laboratories, Genomic Health, Liquid Genomics, Epigenomics, AROS Applied Biotechnology
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
  • Chapter 3: Detailed analysis of Genomic Biomarkers company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
  • Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 12: The main points and conclusions of the report.

FAQ for this report

Who are the main players in the Genomic Biomarkers Market report?

Ans: The main players in the Genomic Biomarkers Market are Thermo Fisher Scientific, Roche, Aepodia, Myriad Genetics, Eurofins Scientific, QIAGEN, Bio-Rad Laboratories, Genomic Health, Liquid Genomics, Epigenomics, AROS Applied Biotechnology

What are the Application segmentation covered in the Genomic Biomarkers Market report?

Ans: The Applications covered in the Genomic Biomarkers Market report are Diagnostic and Research Laboratories, Hospitals, Others

What are the Type segmentation covered in the Genomic Biomarkers Market report?

Ans: The Types covered in the Genomic Biomarkers Market report are Oncology, Cardiovascular Diseases, Neurological Diseases, Others

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Genomic Biomarkers Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Oncology
1.2.3 Cardiovascular Diseases
1.2.4 Neurological Diseases
1.2.5 Others
1.3 Market by Application
1.3.1 Global Genomic Biomarkers Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Diagnostic and Research Laboratories
1.3.3 Hospitals
1.3.4 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Genomic Biomarkers Market Perspective (2020-2031)
2.2 Global Genomic Biomarkers Growth Trends by Region
2.2.1 Global Genomic Biomarkers Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Genomic Biomarkers Historic Market Size by Region (2020-2025)
2.2.3 Genomic Biomarkers Forecasted Market Size by Region (2026-2031)
2.3 Genomic Biomarkers Market Dynamics
2.3.1 Genomic Biomarkers Industry Trends
2.3.2 Genomic Biomarkers Market Drivers
2.3.3 Genomic Biomarkers Market Challenges
2.3.4 Genomic Biomarkers Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Genomic Biomarkers Players by Revenue
3.1.1 Global Top Genomic Biomarkers Players by Revenue (2020-2025)
3.1.2 Global Genomic Biomarkers Revenue Market Share by Players (2020-2025)
3.2 Global Genomic Biomarkers Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Genomic Biomarkers Revenue
3.4 Global Genomic Biomarkers Market Concentration Ratio
3.4.1 Global Genomic Biomarkers Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Genomic Biomarkers Revenue in 2024
3.5 Global Key Players of Genomic Biomarkers Head office and Area Served
3.6 Global Key Players of Genomic Biomarkers, Product and Application
3.7 Global Key Players of Genomic Biomarkers, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Genomic Biomarkers Breakdown Data by Type
4.1 Global Genomic Biomarkers Historic Market Size by Type (2020-2025)
4.2 Global Genomic Biomarkers Forecasted Market Size by Type (2026-2031)
5 Genomic Biomarkers Breakdown Data by Application
5.1 Global Genomic Biomarkers Historic Market Size by Application (2020-2025)
5.2 Global Genomic Biomarkers Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Genomic Biomarkers Market Size (2020-2031)
6.2 North America Genomic Biomarkers Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Genomic Biomarkers Market Size by Country (2020-2025)
6.4 North America Genomic Biomarkers Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Genomic Biomarkers Market Size (2020-2031)
7.2 Europe Genomic Biomarkers Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Genomic Biomarkers Market Size by Country (2020-2025)
7.4 Europe Genomic Biomarkers Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Genomic Biomarkers Market Size (2020-2031)
8.2 Asia-Pacific Genomic Biomarkers Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Genomic Biomarkers Market Size by Region (2020-2025)
8.4 Asia-Pacific Genomic Biomarkers Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Genomic Biomarkers Market Size (2020-2031)
9.2 Latin America Genomic Biomarkers Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Genomic Biomarkers Market Size by Country (2020-2025)
9.4 Latin America Genomic Biomarkers Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Genomic Biomarkers Market Size (2020-2031)
10.2 Middle East & Africa Genomic Biomarkers Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Genomic Biomarkers Market Size by Country (2020-2025)
10.4 Middle East & Africa Genomic Biomarkers Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Thermo Fisher Scientific
11.1.1 Thermo Fisher Scientific Company Details
11.1.2 Thermo Fisher Scientific Business Overview
11.1.3 Thermo Fisher Scientific Genomic Biomarkers Introduction
11.1.4 Thermo Fisher Scientific Revenue in Genomic Biomarkers Business (2020-2025)
11.1.5 Thermo Fisher Scientific Recent Development
11.2 Roche
11.2.1 Roche Company Details
11.2.2 Roche Business Overview
11.2.3 Roche Genomic Biomarkers Introduction
11.2.4 Roche Revenue in Genomic Biomarkers Business (2020-2025)
11.2.5 Roche Recent Development
11.3 Aepodia
11.3.1 Aepodia Company Details
11.3.2 Aepodia Business Overview
11.3.3 Aepodia Genomic Biomarkers Introduction
11.3.4 Aepodia Revenue in Genomic Biomarkers Business (2020-2025)
11.3.5 Aepodia Recent Development
11.4 Myriad Genetics
11.4.1 Myriad Genetics Company Details
11.4.2 Myriad Genetics Business Overview
11.4.3 Myriad Genetics Genomic Biomarkers Introduction
11.4.4 Myriad Genetics Revenue in Genomic Biomarkers Business (2020-2025)
11.4.5 Myriad Genetics Recent Development
11.5 Eurofins Scientific
11.5.1 Eurofins Scientific Company Details
11.5.2 Eurofins Scientific Business Overview
11.5.3 Eurofins Scientific Genomic Biomarkers Introduction
11.5.4 Eurofins Scientific Revenue in Genomic Biomarkers Business (2020-2025)
11.5.5 Eurofins Scientific Recent Development
11.6 QIAGEN
11.6.1 QIAGEN Company Details
11.6.2 QIAGEN Business Overview
11.6.3 QIAGEN Genomic Biomarkers Introduction
11.6.4 QIAGEN Revenue in Genomic Biomarkers Business (2020-2025)
11.6.5 QIAGEN Recent Development
11.7 Bio-Rad Laboratories
11.7.1 Bio-Rad Laboratories Company Details
11.7.2 Bio-Rad Laboratories Business Overview
11.7.3 Bio-Rad Laboratories Genomic Biomarkers Introduction
11.7.4 Bio-Rad Laboratories Revenue in Genomic Biomarkers Business (2020-2025)
11.7.5 Bio-Rad Laboratories Recent Development
11.8 Genomic Health
11.8.1 Genomic Health Company Details
11.8.2 Genomic Health Business Overview
11.8.3 Genomic Health Genomic Biomarkers Introduction
11.8.4 Genomic Health Revenue in Genomic Biomarkers Business (2020-2025)
11.8.5 Genomic Health Recent Development
11.9 Liquid Genomics
11.9.1 Liquid Genomics Company Details
11.9.2 Liquid Genomics Business Overview
11.9.3 Liquid Genomics Genomic Biomarkers Introduction
11.9.4 Liquid Genomics Revenue in Genomic Biomarkers Business (2020-2025)
11.9.5 Liquid Genomics Recent Development
11.10 Epigenomics
11.10.1 Epigenomics Company Details
11.10.2 Epigenomics Business Overview
11.10.3 Epigenomics Genomic Biomarkers Introduction
11.10.4 Epigenomics Revenue in Genomic Biomarkers Business (2020-2025)
11.10.5 Epigenomics Recent Development
11.11 AROS Applied Biotechnology
11.11.1 AROS Applied Biotechnology Company Details
11.11.2 AROS Applied Biotechnology Business Overview
11.11.3 AROS Applied Biotechnology Genomic Biomarkers Introduction
11.11.4 AROS Applied Biotechnology Revenue in Genomic Biomarkers Business (2020-2025)
11.11.5 AROS Applied Biotechnology Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
List of Tables
 Table 1. Global Genomic Biomarkers Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
 Table 2. Key Players of Oncology
 Table 3. Key Players of Cardiovascular Diseases
 Table 4. Key Players of Neurological Diseases
 Table 5. Key Players of Others
 Table 6. Global Genomic Biomarkers Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
 Table 7. Global Genomic Biomarkers Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 8. Global Genomic Biomarkers Market Size by Region (2020-2025) & (US$ Million)
 Table 9. Global Genomic Biomarkers Market Share by Region (2020-2025)
 Table 10. Global Genomic Biomarkers Forecasted Market Size by Region (2026-2031) & (US$ Million)
 Table 11. Global Genomic Biomarkers Market Share by Region (2026-2031)
 Table 12. Genomic Biomarkers Market Trends
 Table 13. Genomic Biomarkers Market Drivers
 Table 14. Genomic Biomarkers Market Challenges
 Table 15. Genomic Biomarkers Market Restraints
 Table 16. Global Genomic Biomarkers Revenue by Players (2020-2025) & (US$ Million)
 Table 17. Global Genomic Biomarkers Market Share by Players (2020-2025)
 Table 18. Global Top Genomic Biomarkers Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Genomic Biomarkers as of 2024)
 Table 19. Ranking of Global Top Genomic Biomarkers Companies by Revenue (US$ Million) in 2024
 Table 20. Global 5 Largest Players Market Share by Genomic Biomarkers Revenue (CR5 and HHI) & (2020-2025)
 Table 21. Global Key Players of Genomic Biomarkers, Headquarters and Area Served
 Table 22. Global Key Players of Genomic Biomarkers, Product and Application
 Table 23. Global Key Players of Genomic Biomarkers, Date of Enter into This Industry
 Table 24. Mergers & Acquisitions, Expansion Plans
 Table 25. Global Genomic Biomarkers Market Size by Type (2020-2025) & (US$ Million)
 Table 26. Global Genomic Biomarkers Revenue Market Share by Type (2020-2025)
 Table 27. Global Genomic Biomarkers Forecasted Market Size by Type (2026-2031) & (US$ Million)
 Table 28. Global Genomic Biomarkers Revenue Market Share by Type (2026-2031)
 Table 29. Global Genomic Biomarkers Market Size by Application (2020-2025) & (US$ Million)
 Table 30. Global Genomic Biomarkers Revenue Market Share by Application (2020-2025)
 Table 31. Global Genomic Biomarkers Forecasted Market Size by Application (2026-2031) & (US$ Million)
 Table 32. Global Genomic Biomarkers Revenue Market Share by Application (2026-2031)
 Table 33. North America Genomic Biomarkers Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 34. North America Genomic Biomarkers Market Size by Country (2020-2025) & (US$ Million)
 Table 35. North America Genomic Biomarkers Market Size by Country (2026-2031) & (US$ Million)
 Table 36. Europe Genomic Biomarkers Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 37. Europe Genomic Biomarkers Market Size by Country (2020-2025) & (US$ Million)
 Table 38. Europe Genomic Biomarkers Market Size by Country (2026-2031) & (US$ Million)
 Table 39. Asia-Pacific Genomic Biomarkers Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 40. Asia-Pacific Genomic Biomarkers Market Size by Region (2020-2025) & (US$ Million)
 Table 41. Asia-Pacific Genomic Biomarkers Market Size by Region (2026-2031) & (US$ Million)
 Table 42. Latin America Genomic Biomarkers Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 43. Latin America Genomic Biomarkers Market Size by Country (2020-2025) & (US$ Million)
 Table 44. Latin America Genomic Biomarkers Market Size by Country (2026-2031) & (US$ Million)
 Table 45. Middle East & Africa Genomic Biomarkers Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 46. Middle East & Africa Genomic Biomarkers Market Size by Country (2020-2025) & (US$ Million)
 Table 47. Middle East & Africa Genomic Biomarkers Market Size by Country (2026-2031) & (US$ Million)
 Table 48. Thermo Fisher Scientific Company Details
 Table 49. Thermo Fisher Scientific Business Overview
 Table 50. Thermo Fisher Scientific Genomic Biomarkers Product
 Table 51. Thermo Fisher Scientific Revenue in Genomic Biomarkers Business (2020-2025) & (US$ Million)
 Table 52. Thermo Fisher Scientific Recent Development
 Table 53. Roche Company Details
 Table 54. Roche Business Overview
 Table 55. Roche Genomic Biomarkers Product
 Table 56. Roche Revenue in Genomic Biomarkers Business (2020-2025) & (US$ Million)
 Table 57. Roche Recent Development
 Table 58. Aepodia Company Details
 Table 59. Aepodia Business Overview
 Table 60. Aepodia Genomic Biomarkers Product
 Table 61. Aepodia Revenue in Genomic Biomarkers Business (2020-2025) & (US$ Million)
 Table 62. Aepodia Recent Development
 Table 63. Myriad Genetics Company Details
 Table 64. Myriad Genetics Business Overview
 Table 65. Myriad Genetics Genomic Biomarkers Product
 Table 66. Myriad Genetics Revenue in Genomic Biomarkers Business (2020-2025) & (US$ Million)
 Table 67. Myriad Genetics Recent Development
 Table 68. Eurofins Scientific Company Details
 Table 69. Eurofins Scientific Business Overview
 Table 70. Eurofins Scientific Genomic Biomarkers Product
 Table 71. Eurofins Scientific Revenue in Genomic Biomarkers Business (2020-2025) & (US$ Million)
 Table 72. Eurofins Scientific Recent Development
 Table 73. QIAGEN Company Details
 Table 74. QIAGEN Business Overview
 Table 75. QIAGEN Genomic Biomarkers Product
 Table 76. QIAGEN Revenue in Genomic Biomarkers Business (2020-2025) & (US$ Million)
 Table 77. QIAGEN Recent Development
 Table 78. Bio-Rad Laboratories Company Details
 Table 79. Bio-Rad Laboratories Business Overview
 Table 80. Bio-Rad Laboratories Genomic Biomarkers Product
 Table 81. Bio-Rad Laboratories Revenue in Genomic Biomarkers Business (2020-2025) & (US$ Million)
 Table 82. Bio-Rad Laboratories Recent Development
 Table 83. Genomic Health Company Details
 Table 84. Genomic Health Business Overview
 Table 85. Genomic Health Genomic Biomarkers Product
 Table 86. Genomic Health Revenue in Genomic Biomarkers Business (2020-2025) & (US$ Million)
 Table 87. Genomic Health Recent Development
 Table 88. Liquid Genomics Company Details
 Table 89. Liquid Genomics Business Overview
 Table 90. Liquid Genomics Genomic Biomarkers Product
 Table 91. Liquid Genomics Revenue in Genomic Biomarkers Business (2020-2025) & (US$ Million)
 Table 92. Liquid Genomics Recent Development
 Table 93. Epigenomics Company Details
 Table 94. Epigenomics Business Overview
 Table 95. Epigenomics Genomic Biomarkers Product
 Table 96. Epigenomics Revenue in Genomic Biomarkers Business (2020-2025) & (US$ Million)
 Table 97. Epigenomics Recent Development
 Table 98. AROS Applied Biotechnology Company Details
 Table 99. AROS Applied Biotechnology Business Overview
 Table 100. AROS Applied Biotechnology Genomic Biomarkers Product
 Table 101. AROS Applied Biotechnology Revenue in Genomic Biomarkers Business (2020-2025) & (US$ Million)
 Table 102. AROS Applied Biotechnology Recent Development
 Table 103. Research Programs/Design for This Report
 Table 104. Key Data Information from Secondary Sources
 Table 105. Key Data Information from Primary Sources
 Table 106. Authors List of This Report


List of Figures
 Figure 1. Genomic Biomarkers Picture
 Figure 2. Global Genomic Biomarkers Market Size Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Genomic Biomarkers Market Share by Type: 2024 VS 2031
 Figure 4. Oncology Features
 Figure 5. Cardiovascular Diseases Features
 Figure 6. Neurological Diseases Features
 Figure 7. Others Features
 Figure 8. Global Genomic Biomarkers Market Size by Application (2020-2031) & (US$ Million)
 Figure 9. Global Genomic Biomarkers Market Share by Application: 2024 VS 2031
 Figure 10. Diagnostic and Research Laboratories Case Studies
 Figure 11. Hospitals Case Studies
 Figure 12. Others Case Studies
 Figure 13. Genomic Biomarkers Report Years Considered
 Figure 14. Global Genomic Biomarkers Market Size (US$ Million), Year-over-Year: 2020-2031
 Figure 15. Global Genomic Biomarkers Market Size, (US$ Million), 2020 VS 2024 VS 2031
 Figure 16. Global Genomic Biomarkers Market Share by Region: 2024 VS 2031
 Figure 17. Global Genomic Biomarkers Market Share by Players in 2024
 Figure 18. Global Top Genomic Biomarkers Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Genomic Biomarkers as of 2024)
 Figure 19. The Top 10 and 5 Players Market Share by Genomic Biomarkers Revenue in 2024
 Figure 20. North America Genomic Biomarkers Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 21. North America Genomic Biomarkers Market Share by Country (2020-2031)
 Figure 22. United States Genomic Biomarkers Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 23. Canada Genomic Biomarkers Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 24. Europe Genomic Biomarkers Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 25. Europe Genomic Biomarkers Market Share by Country (2020-2031)
 Figure 26. Germany Genomic Biomarkers Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 27. France Genomic Biomarkers Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 28. U.K. Genomic Biomarkers Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 29. Italy Genomic Biomarkers Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 30. Russia Genomic Biomarkers Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 31. Nordic Countries Genomic Biomarkers Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 32. Asia-Pacific Genomic Biomarkers Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 33. Asia-Pacific Genomic Biomarkers Market Share by Region (2020-2031)
 Figure 34. China Genomic Biomarkers Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 35. Japan Genomic Biomarkers Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 36. South Korea Genomic Biomarkers Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 37. Southeast Asia Genomic Biomarkers Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 38. India Genomic Biomarkers Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 39. Australia Genomic Biomarkers Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 40. Latin America Genomic Biomarkers Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 41. Latin America Genomic Biomarkers Market Share by Country (2020-2031)
 Figure 42. Mexico Genomic Biomarkers Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 43. Brazil Genomic Biomarkers Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 44. Middle East & Africa Genomic Biomarkers Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 45. Middle East & Africa Genomic Biomarkers Market Share by Country (2020-2031)
 Figure 46. Turkey Genomic Biomarkers Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 47. Saudi Arabia Genomic Biomarkers Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 48. UAE Genomic Biomarkers Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 49. Thermo Fisher Scientific Revenue Growth Rate in Genomic Biomarkers Business (2020-2025)
 Figure 50. Roche Revenue Growth Rate in Genomic Biomarkers Business (2020-2025)
 Figure 51. Aepodia Revenue Growth Rate in Genomic Biomarkers Business (2020-2025)
 Figure 52. Myriad Genetics Revenue Growth Rate in Genomic Biomarkers Business (2020-2025)
 Figure 53. Eurofins Scientific Revenue Growth Rate in Genomic Biomarkers Business (2020-2025)
 Figure 54. QIAGEN Revenue Growth Rate in Genomic Biomarkers Business (2020-2025)
 Figure 55. Bio-Rad Laboratories Revenue Growth Rate in Genomic Biomarkers Business (2020-2025)
 Figure 56. Genomic Health Revenue Growth Rate in Genomic Biomarkers Business (2020-2025)
 Figure 57. Liquid Genomics Revenue Growth Rate in Genomic Biomarkers Business (2020-2025)
 Figure 58. Epigenomics Revenue Growth Rate in Genomic Biomarkers Business (2020-2025)
 Figure 59. AROS Applied Biotechnology Revenue Growth Rate in Genomic Biomarkers Business (2020-2025)
 Figure 60. Bottom-up and Top-down Approaches for This Report
 Figure 61. Data Triangulation
 Figure 62. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Nano Dimension

RELATED REPORTS

Global Pharma and Healthcare Social Media Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-14Y6812
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Food Additives Testing Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-34O3983
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Gabapentin API Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-9V17601
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Electronic Informed Consent Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-22C17047
Fri Sep 12 00:00:00 UTC 2025

Add to Cart